Maternal serum marker analyser, reagents and consumables for assessing trisomy 21 and pre-eclampsia risk

Summary

The tender covers the provision of a maternal serum marker analyser and the supply of reagents and consumables for assessing the risk of trisomy 21 and pre-eclampsia during pregnancy. The supplier must also maintain the analyser, including providing spare parts, train users and supply the software needed to calculate risk. The equipment will be installed in the biochemistry department of the Marseille hospitals. This is a 60-month framework agreement performed through individual orders, with no minimum volume and a maximum total value of EUR 520,000 excluding VAT. Services are paid at unit prices. Bids must be submitted electronically by 12:00 on 2 November 2026. The evaluation assigns 50% to the overall cost of the solution, 40% to technical quality and 10% to environmental performance.